Oxyphen XR, 12 HR / CLINICAL STRENGTH FAT BURNER, 45 FAST ACTING EXTENDED RELEASE CAPSULES
Recalling firm: Beta Labs
Why it was recalled
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Check your package
Compare the exact product and package details with the label you have.
ProductOxyphen XR, 12 HR / CLINICAL STRENGTH FAT BURNER, 45 FAST ACTING EXTENDED RELEASE CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599747
UPC670541599747
FDA code information
Lot #s 200910 and 200911, Exp 10/16
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Oxyphen XR, 12 HR / CLINICAL STRENGTH FAT BURNER, 45 FAST ACTING EXTENDED RELEASE CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599747
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 670541599747 | XTENDED RELEASE CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599747 |
Recall details
- Recall number
- F-2398-2014
- Event ID
- 65585
- FDA status
- Terminated
- Initiated
- Jun 20, 2013
- Reported
- Sep 3, 2014
- Classified
- Aug 27, 2014
- Terminated
- Dec 3, 2014
- Quantity
- 5951 units
- Location
- Memphis, TN, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
nationwide and UK
FDA source record · F-2398-2014
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.